Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVB
701
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $10.3M | 0.01% |
+429,026
| New | +$5.38M |
|
702
Wayfair
W
$14.1B
| $10.3M | 0.01% |
300,284
+16,218
| +6% | +$718K |
|
703
Lockheed Martin
LMT
$138B
| $10.3M | 0.01% |
21,805
-8,273
| -28% | -$3.88M |
|
704
Micron Technology
MU
$981B
| $10.2M | 0.01% |
168,921
+33,854
| +25% | +$1.98M |
|
705
US Foods
USFD
$23.9B
| $9.99M | 0.01% |
270,287
+191,623
| +244% | +$7.1M |
|
706
Liberty Global Class A
LBTYA
$3.48B
| $9.94M | 0.01% |
509,496
+12,938
| +3% | +$263K |
|
707
General Mills
GIS
$20.2B
| $9.81M | 0.01% |
114,811
-121,351
| -51% | -$9.69M |
|
708
Expensify
EXFY
$211M
| $9.73M | 0.01% |
1,194,007
+489,895
| +70% | +$4.36M |
|
709
Nasdaq
NDAQ
$53.1B
| $9.73M | 0.01% |
178,005
+80,438
| +82% | +$4.65M |
|
710
SSR Mining
SSRM
$6.52B
| $9.65M | 0.01% |
639,138
+39,042
| +7% | +$595K |
|
711
CSX Corp
CSX
$92.5B
| $9.61M | 0.01% |
321,025
-33,005
| -9% | -$1.01M |
|
712
Dow Inc
DOW
$22.6B
| $9.57M | 0.01% |
174,653
+85,632
| +96% | +$4.82M |
|
713
US Bancorp
USB
$100B
| $9.56M | 0.01% |
265,270
-832,587
| -76% | -$37.1M |
|
714
Hudbay
HBM
$12.3B
| $9.55M | 0.01% |
1,821,497
+1,638,521
| +895% | +$8.62M |
|
|
ZING
715
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $9.52M | 0.01% |
926,485
-263
| -0% | -$2.68K |
|
716
Cintas
CTAS
$82.1B
| $9.49M | 0.01% |
82,092
+38,304
| +87% | +$4.22M |
|
717
3M
MMM
$94.4B
| $9.47M | 0.01% |
107,809
-10,544
| -9% | -$994K |
|
718
Vor Biopharma
VOR
$1.28B
| $9.46M | 0.01% |
88,244
-4,779
| -5% | -$530K |
|
719
Otis Worldwide
OTIS
$27.8B
| $9.29M | 0.01% |
110,165
-367,608
| -77% | -$30.4M |
|
|
KYNB
720
Kyntra Bio
KYNB
$28.6M
| $9.08M | 0.01% |
19,466
+4,432
| +29% | +$2.34M |
|
721
IDEAYA Biosciences
IDYA
$3.55B
| $9.05M | 0.01% |
657,897
-26,080
| -4% | -$434K |
|
722
Paychex
PAYX
$43.1B
| $9.01M | 0.01% |
78,617
+190
| +0.2% | +$21.6K |
|
723
AST SpaceMobile
ASTS
$21.4B
| $9M | 0.01% |
1,772,152
-199
| -0% | -$1.15K |
|
724
Amprius Technologies
AMPX
$1.76B
| $8.92M | 0.01% |
1,024,580
-4,847
| -0.5% | -$30.6K |
|
725
Yum! Brands
YUM
$39.5B
| $8.91M | 0.01% |
67,505
-17,617
| -21% | -$2.27M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.